ATS Medical Announces Second Quart...(31071 Other ...),Health

Other 31 62

Net cash provided by financing activities 2,750 37,406

Effect of foreign exchange rate changes (117) (89)

Increase in cash and cash equivalents $427 $13,162

ATS Medical, Inc.

Selected Revenue Information

(in thousands)

Quarter Ended Six Months Ended

June 28, June 30, June 28, June 30,

2008 2007 2008 2007

Heart valve therapy $12,093 $10,780 $22,774 $19,771

Surgical arrhythmia 4,386 1,341 8,234 2,819

Surgical tools &

accessories 421 296 737 623

Total revenue $16,900 $12,417 $31,745 $23,213

ATS Medical, Inc.

Reconciliation of GAAP Financial Measures to Non-GAAP Financial Measures

(in thousands)

Unaudited

Quarter Ended

June 28, 2008

Net loss, as reported $(4,669)

Adjustment to net loss:

Mark to market charge-ALTA warrant 1,278

Net loss, as adjusted $(3,391)

Net loss per share, as reported:

Basic and diluted $(0.08)

Adjustment to net loss per share:

Mark to market charge-ALTA warrant 0.02

Net loss per share, as adjusted:

Basic and diluted $(0.06)

Weighted average number of shares outstanding,

basic and diluted 60,018